Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemizole in Hepatocellular Carcinoma
NCT03069508Phase 2Unknown
- Sponsor
- Eiger Group International Inc
- Start
- Feb 2017
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of clemizole in hepatocellular carcinoma (HCC), sponsored by Eiger Group International Inc. Status: unknown.
02
Drugs
clemizole
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03069508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069508.